...
首页> 外文期刊>Cell death & disease. >REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival
【24h】

REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival

机译:REP1抑制FOXO3介导的凋亡以促进癌细胞存活

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Rab escort protein 1 (REP1) is a component of Rab geranyl-geranyl transferase 2 complex. Mutations in REP1 cause a disease called choroideremia (CHM), which is an X-linked eye disease. Although it is postulated that REP1 has functions in cell survival or death of various tissues in addition to the eye, how REP1 functions in normal and cancer cells remains to be elucidated. Here, we demonstrated that REP1 is required for the survival of intestinal cells in addition to eyes or a variety of cells in zebrafish, and also has important roles in tumorigenesis. Notably, REP1 is highly expressed in colon cancer tissues and cell lines, and silencing of REP1 sensitizes colon cancer cells to serum starvation- and 5-FU-induced apoptosis. In an effort to elucidate the molecular mechanisms underlying REP1-mediated cell survival under those stress conditions, we identified FOXO3 as a binding partner of REP1 using a yeast two-hybrid (Y2H) assay system, and we demonstrated that REP1 blocked the nuclear trans-localization of FOXO3 through physically interacting with FOXO3, thereby suppressing FOXO3-mediated apoptosis. Importantly, the inhibition of REP1 combined with 5-FU treatment could lead to significant retarded tumor growth in a xenograft tumor model of human cancer cells. Thus, our results suggest that REP1 could be a new therapeutic target in combination treatment for colon cancer patients.
机译:Rab伴游蛋白1(REP1)是Rab香叶基-香叶基转移酶2复合物的组成部分。 REP1中的突变会导致一种称为脉络膜血友病(CHM)的疾病,该疾病是X连锁眼病。尽管假定REP1在除了眼睛之外还具有细胞存活或各种组织死亡的功能,但是REP1如何在正常细胞和癌细胞中起作用尚待阐明。在这里,我们证明了REP1是除了眼睛或斑马鱼中各种细胞之外的肠道细胞生存所必需的,并且在肿瘤发生中也具有重要作用。值得注意的是,REP1在结肠癌组织和细胞系中高表达,而REP1的沉默会使结肠癌细胞对血清饥饿和5-FU诱导的细胞凋亡敏感。为了阐明在这些压力条件下REP1介导的细胞存活的分子机制,我们使用酵母双杂交(Y2H)分析系统将FOXO3鉴定为REP1的结合伴侣,并且我们证明REP1阻断了核反式通过与FOXO3物理相互作用来定位FOXO3,从而抑制FOXO3介导的凋亡。重要的是,在人类癌细胞的异种移植肿瘤模型中,结合REP1-5-FU处理的抑制作用可能导致明显的肿瘤生长迟缓。因此,我们的结果表明,REP1可能成为结肠癌患者联合治疗的新治疗靶标。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号